Works matching AU Vanmechelen, Eugeen

Results: 136

Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study.

Published in:

Dementia & Geriatric Cognitive Disorders Extra, 2018, v. 8, n. 2, p. 277, doi. 10.1159/000489847

By:

Schipke, Carola G.;
De Vos, Ann;
Fuentes, Manuel;
Jacobs, Dirk;
Vanmechelen, Eugeen;
Peters, Oliver

Publication type:

Article

NEuroBioStand project: a European metrological research framework for standardising p‐tau measurements in plasma.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092203

By:

Giangrande, Chiara;
Vaneeckhoutte, Hélène;
Delatour, Vincent;
Vinh, Joëlle;
Verdier, Yann;
Vanmechelen, Eugeen;
Koertvelyessy, Peter;
Blennow, Kaj;
Zetterberg, Henrik;
Gobom, Johan

Publication type:

Article

Plasma biomarkers combinations for prescreening rapid amyloid accumulation in cognitively unimpaired individuals at‐risk of Alzheimer's disease.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.091423

By:

Contador, José;
Milà‐Alomà, Marta;
Escalante, Armand González;
Ashton, Nicholas J.;
Shekari, Mahnaz;
Ortiz‐Romero, Paula;
Karikari, Thomas K;
Vanmechelen, Eugeen;
Day, Theresa A.;
Dage, Jeffrey L.;
Zetterberg, Henrik;
Gispert, Juan Domingo;
Blennow, Kaj;
Suarez‐Calvet, Marc

Publication type:

Article

Associations between blood‐based biomarkers, synaptic density and Alzheimer's disease hallmarks in the brains of nondemented elderly.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.090738

By:

Meyer, Steffi De;
Alali, Soha;
Laroy, Maarten;
Casteele, Thomas Vande;
Cauwenberge, Margot Van;
Goossens, Julie;
Rocker, Charlotte De;
Vanbrabant, Jeroen;
Vanmechelen, Eugeen;
Dupont, Patrick;
Laere, Koen Van;
Vandenbulcke, Mathieu;
Emsell, Louise;
Poesen, Koen

Publication type:

Article

Prognostic value of a novel plasma pTau217 assay for amyloid accumulation in healthy elderly.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.088710

By:

Meyer, Steffi De;
Luckett, Emma S.;
Schaeverbeke, Jolien;
Laere, Koen Van;
Vanbrabant, Jeroen;
Vanmechelen, Eugeen;
Dupont, Patrick;
Molfetta, Guglielmo Di;
Zetterberg, Henrik;
Ashton, Nicholas J.;
Poesen, Koen;
Vandenberghe, Rik

Publication type:

Article

Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5324, doi. 10.1002/alz.13907

By:

Emeršič, Andreja;
Ashton, Nicholas J.;
Vrillon, Agathe;
Lantero‐Rodriguez, Juan;
Mlakar, Jernej;
Gregorič Kramberger, Milica;
Gonzalez‐Ortiz, Fernando;
Kac, Przemysław R.;
Dulewicz, Maciej;
Hanrieder, Jörg;
Vanmechelen, Eugeen;
Rot, Uroš;
Zetterberg, Henrik;
Karikari, Thomas K.;
Čučnik, Saša;
Blennow, Kaj

Publication type:

Article

Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer's disease; relation to cognition, atrophy and synaptic density.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083128

By:

Sauer, Mathias;
De Rocker, Charlotte;
Grötschel, Lana;
Goossens, Julie;
Benedet, Andrea L.;
Schöll, Michael;
Nilsson, Johanna;
Brinkmalm, Ann;
Janelidze, Shorena;
Stomrud, Erik;
O'Brien, John T;
Chouliaras, Leonidas;
Malpetti, Maura;
Rosa‐Neto, Pedro;
Rowe, James B.;
Zetterberg, Henrik;
Blennow, Kaj;
Hansson, Oskar;
Vanmechelen, Eugeen;
Ashton, Nicholas J.

Publication type:

Article

The detection of phosphorylated tau in tear fluid.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083029

By:

Molfetta, Guglielmo Di;
Demleitner, Antonia Franziska;
Gomes, Lucas Arujo Caldi;
Jeromin, Andreas;
Vanmechelen, Eugeen;
Blennow, Kaj;
Zetterberg, Henrik;
Lingor, Paul;
Ashton, Nicholas J.

Publication type:

Article

Optimizing plasma biomarkers combinations for the detection of amyloid pathology in cognitively unimpaired individuals.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082742

By:

Contador, José;
Milà‐Alomà, Marta;
Escalante, Armand González;
Ashton, Nicholas J.;
Shekari, Mahnaz;
Ortiz‐Romero, Paula;
Karikari, Thomas K;
Vanmechelen, Eugeen;
Day, Theresa A.;
Dage, Jeff L.;
Zetterberg, Henrik;
Gispert, Juan Domingo;
Blennow, Kaj;
Suárez‐Calvet, Marc

Publication type:

Article

Bioinformatics tools and data resources for assay development of fluid protein biomarkers.

Published in:

Biomarker Research, 2022, v. 10, p. 1, doi. 10.1186/s40364-022-00425-w

By:

Waury, Katharina;
Willemse, Eline A. J.;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Teunissen, Charlotte E.;
Abeln, Sanne

Publication type:

Article

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.

Published in:

JAMA Neurology, 2024, v. 81, n. 3, p. 255, doi. 10.1001/jamaneurol.2023.5319

By:

Ashton, Nicholas J.;
Brum, Wagner S.;
Di Molfetta, Guglielmo;
Benedet, Andrea L.;
Arslan, Burak;
Jonaitis, Erin;
Langhough, Rebecca E.;
Cody, Karly;
Wilson, Rachael;
Carlsson, Cynthia M.;
Vanmechelen, Eugeen;
Montoliu-Gaya, Laia;
Lantero-Rodriguez, Juan;
Rahmouni, Nesrine;
Tissot, Cecile;
Stevenson, Jenna;
Servaes, Stijn;
Therriault, Joseph;
Pascoal, Tharick;
Lleó, Alberto

Publication type:

Article

Cerebrospinal fluid neurogranin in Alzheimer's disease studies: are immunoassay results interchangeable?

Published in:

2022

By:

Aveneau, Clément;
Hourregue, Claire;
Cognat, Emmanuel;
Dumurgier, Julien;
Vanderstichele, Hugo;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Hugon, Jacques;
Blennow, Kaj;
Paquet, Claire;
Bouaziz-Amar, Elodie

Publication type:

Letter

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.

Published in:

Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 7, p. 1177, doi. 10.1515/cclm-2015-0733

By:

Bjerke, Maria;
Andreasson, Ulf;
Kuhlmann, Julia;
Portelius, Erik;
Pannee, Josef;
Lewczuk, Piotr;
Umek, Robert M.;
Vanmechelen, Eugeen;
Vanderstichele, Hugo;
Stoops, Erik;
Lewis, Jennifer;
Vandijck, Manu;
Kostanjevecki, Vesna;
Jeromin, Andreas;
Salamone, Salvatore J.;
Schmidt, Oliver;
Matzen, Anja;
Madin, Kairat;
Eichenlaub, Udo;
Bittner, Tobias

Publication type:

Article

Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.

Published in:

Clinical Chemistry & Laboratory Medicine, 2006, v. 44, n. 12, p. 1472, doi. 10.1515/CCLM.2006.258

By:

Vanderstichele, Hugo;
De Vreese, Karen;
Blennow, Kaj;
Andreasen, Niels;
Sindic, Christian;
Ivanoiu, Adrian;
Hampel, Harald;
Bürger, Katharina;
Parnetti, Lucilla;
Lanari, Alessia;
Padovani, Allesandro;
DiLuca, Monica;
Bläser, Miriam;
Ohrfelt Olsson, Annika;
Pottel, Hans;
Hulstaert, Frank;
Vanmechelen, Eugeen

Publication type:

Article

Multicenter Analytical Validation of Aβ40 Immunoassays.

Published in:

Frontiers in Neurology, 2017, p. 1, doi. 10.3389/fneur.2017.00310

By:

van Waalwijk van Doorn, Linda J. C.;
Kulic, Luka;
Koel-Simmelink, Marleen J. A.;
Kuiperij, H. Bea;
Versleijen, Alexandra A. M.;
Struyfs, Hanne;
Twaalfhoven, Harry A. M.;
Fourier, Anthony;
Engelborghs, Sebastiaan;
Perret-Liaudet, Armand;
Lehmann, Sylvain;
Verbeek, Marcel M.;
Vanmechelen, Eugeen J. M.;
Teunissen, Charlotte E.

Publication type:

Article

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.

Published in:

PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153564

By:

Kruse, Niels;
Schlossmacher, Michael G.;
Schulz-Schaeffer, Walter J.;
Vanmechelen, Eugeen;
Vanderstichele, Hugo;
El-Agnaf, Omar M.;
Mollenhauer, Brit

Publication type:

Article

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7221, doi. 10.3390/ijms23137221

By:

Das, Shreyasee;
Dewit, Nele;
Jacobs, Dirk;
Pijnenburg, Yolande A. L.;
In 't Veld, Sjors G. J. G.;
Coppens, Salomé;
Quaglia, Milena;
Hirtz, Christophe;
Teunissen, Charlotte E.;
Vanmechelen, Eugeen

Publication type:

Article

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.

Published in:

Acta Neuropathologica Communications, 2015, v. 3, n. 1, p. 1, doi. 10.1186/s40478-015-0195-1

By:

Goossens, Joery;
Vanmechelen, Eugeen;
Trojanowski, John Q.;
Lee, Virginia M. Y.;
Van Broeckhoven, Christine;
van der Zee, Julie;
Engelborghs, Sebastiaan

Publication type:

Article

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.

Published in:

Acta Neuropathologica Communications, 2015, v. 3, n. 1, p. 1, doi. 10.1186/s40478-015-0195-1

By:

Goossens, Joery;
Vanmechelen, Eugeen;
Trojanowski, John Q.;
Lee, Virginia M. Y.;
Van Broeckhoven, Christine;
van der Zee, Julie;
Engelborghs, Sebastiaan

Publication type:

Article

Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased ABeta42 secretion.

Published in:

Human Molecular Genetics, 1999, v. 8, n. 8, p. 1529, doi. 10.1093/hmg/8.8.1529

By:

Jonghe, Chris De;
Cruts, Marc;
Rogaeva, Ekaterina A.;
Tysoe, Carolyn;
Singleton, Andrew;
Vanderstichele, Hugo;
Meschino, Wendy;
Dermaut, Bart;
Vanderhoeven, Inge;
Backhovens, Hubert;
Vanmechelen, Eugeen;
Morris, Christopher M.;
Hardy, John;
Rubinsztein, David C.;
St. George-Hyslop, Peter H.;
Van Broeckhoven, Christine

Publication type:

Article

The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.

Published in:

Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01409-8

By:

Das, Shreyasee;
van Engelen, Marie-Paule E.;
Goossens, Julie;
Jacobs, Dirk;
Bongers, Bram;
Fieldhouse, Jay L. P.;
Pijnenburg, Yolande A. L.;
Teunissen, Charlotte E.;
Vanmechelen, Eugeen;
Verberk, Inge M. W.

Publication type:

Article

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum.

Published in:

Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01336-0

By:

Goossens, Julie;
Cervantes González, Alba;
Dewit, Nele;
Lidón, Laia;
Fortea, Juan;
Alcolea, Daniel;
Lleó, Alberto;
Belbin, Olivia;
Vanmechelen, Eugeen

Publication type:

Article

Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia.

Published in:

Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01212-x

By:

Das, Shreyasee;
Goossens, Julie;
Jacobs, Dirk;
Dewit, Nele;
Pijnenburg, Yolande A. L.;
In 't Veld, Sjors G. J. G.;
Teunissen, Charlotte E.;
Vanmechelen, Eugeen

Publication type:

Article

P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.

Published in:

Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01038-z

By:

Wesenhagen, Kirsten E. J.;
Tijms, Betty M.;
Boonkamp, Lynn;
Hoede, Patty L.;
Goossens, Julie;
Dewit, Nele;
Scheltens, Philip;
Vanmechelen, Eugeen;
Visser, Pieter Jelle;
Teunissen, Charlotte E.

Publication type:

Article

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method.

Published in:

Neurochemical Research, 2011, v. 36, n. 11, p. 2029, doi. 10.1007/s11064-011-0527-x

By:

Öhrfelt, Annika;
Zetterberg, Henrik;
Andersson, Kerstin;
Persson, Rita;
Secic, Dzemila;
Brinkmalm, Gunnar;
Wallin, Anders;
Mulugeta, Ezra;
Francis, Paul;
Vanmechelen, Eugeen;
Aarsland, Dag;
Ballard, Clive;
Blennow, Kaj;
Westman-Brinkmalm, Ann

Publication type:

Article

Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.

Published in:

Annals of Neurology, 2005, v. 58, n. 5, p. 748

By:

Khalid Iqbal;
Michael Flory;
Sabiha Khatoon;
Hilkka Soininen;
Tuula Pirttila;
Maarit Lehtovirta;
Irina Alafuzoff;
Kaj Blennow;
Niels Andreasen;
Eugeen Vanmechelen;
Inge Grundke‐Iqbal

Publication type:

Article

Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma.

Published in:

Amyloid, 2000, v. 7, n. 4, p. 245, doi. 10.3109/13506120009146438

By:

Vanderstichele, Hugo;
Kerschaver, Els Van;
Hesse, Camilla;
Davidsson, Pia;
Buyse, Marie-Ange;
Andreasen, Niels;
Minthon, Lennart;
Wallin, Anders;
Blennow, Kaj;
Vanmechelen, Eugeen

Publication type:

Article

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

Published in:

EMBO Molecular Medicine, 2020, v. 12, n. 12, p. 1, doi. 10.15252/emmm.202012921

By:

Suárez‐Calvet, Marc;
Karikari, Thomas K;
Ashton, Nicholas J;
Lantero Rodríguez, Juan;
Milà‐Alomà, Marta;
Gispert, Juan Domingo;
Salvadó, Gemma;
Minguillon, Carolina;
Fauria, Karine;
Shekari, Mahnaz;
Grau‐Rivera, Oriol;
Arenaza‐Urquijo, Eider M;
Sala‐Vila, Aleix;
Sánchez‐Benavides, Gonzalo;
González‐de‐Echávarri, José Maria;
Kollmorgen, Gwendlyn;
Stoops, Erik;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Blennow, Kaj

Publication type:

Article

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

Published in:

Expert Review of Proteomics, 2008, v. 5, n. 2, p. 207, doi. 10.1586/14789450.5.2.207

By:

Sergeant, Nicolas;
Bretteville, Alexis;
Hamdane, Malika;
Caillet-Boudin, Marie-Laure;
Grognet, Pierre;
Bombois, Stephanie;
Blum, David;
Delacourte, André;
Pasquier, Florence;
Vanmechelen, Eugeen;
Schraen-Maschke, Susanna;
Buée, Luc

Publication type:

Article

Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.

Published in:

Journal of Neurochemistry, 2016, v. 137, n. 1, p. 112, doi. 10.1111/jnc.13527

By:

Waalwijk van Doorn, Linda J.C.;
Koel‐Simmelink, Marleen J.;
Haußmann, Ute;
Klafki, Hans;
Struyfs, Hanne;
Linning, Philipp;
Knölker, Hans‐Joachim;
Twaalfhoven, Harry;
Kuiperij, H. Bea;
Engelborghs, Sebastiaan;
Scheltens, Philip;
Verbeek, Marcel M.;
Vanmechelen, Eugeen;
Wiltfang, Jens;
Teunissen, Charlotte E.

Publication type:

Article

Decreased CSF-β-Amyloid 42 in Alzheimer's Disease and Amyotrophic Lateral Sclerosis May Reflect Mismetabolism of β-Amyloid Induced by Disparate Mechanisms.

Published in:

Dementia & Geriatric Cognitive Disorders, 2002, v. 13, n. 2, p. 112, doi. 10.1159/000048642

By:

Sjögren, Magnus;
Davidsson, Pia;
Wallin, Anders;
Granérus, Ann-Kathrine;
Grundström, Eva;
Askmark, Håkan;
Vanmechelen, Eugeen;
Blennow, Kaj

Publication type:

Article

The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer's Disease, Reflecting a Common Pathophysiological Process.

Published in:

Dementia & Geriatric Cognitive Disorders, 2001, v. 12, n. 4, p. 257, doi. 10.1159/000051268

By:

Sjögren, Magnus;
Davidsson, Pia;
Gottfries, Johan;
Vanderstichele, Hugo;
Edman, Åke;
Vanmechelen, Eugeen;
Wallin, Anders;
Blennow, Kaj

Publication type:

Article

Tau Immunoreactivity Detected in Human Plasma, But No Obvious Increase in Dementia.

Published in:

Dementia & Geriatric Cognitive Disorders, 1999, v. 10, n. 6, p. 442, doi. 10.1159/000017187

By:

Ingelson, Martin;
Blomberg, Mari;
Benedikz, Eirikur;
Wahlund, Lars-Olof;
Karlsson, Evert;
Vanmechelen, Eugeen;
Lannfelt, Lars

Publication type:

Article

Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach.

Published in:

Journal of Neurochemistry, 2003, v. 85, n. 6, p. 1581, doi. 10.1046/j.1471-4159.2003.01818.x

By:

Sergeant, Nicolas;
Bombois, Stepanie;
Ghestem, Antoine;
Drobecq, Hervé;
Kostanjevecki, Vesna;
Missiaen, Carla;
Wattez, Annick;
David, Jean-Phillipe;
Vanmechelen, Eugeen;
Sergheraert, Christian;
Delacourte, André

Publication type:

Article

Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme-Linked Immunosorbent Assay.

Published in:

Journal of Neurochemistry, 1993, v. 61, n. 5, p. 1828, doi. 10.1111/j.1471-4159.1993.tb09823.x

By:

Vandermeeren, Marc;
Mercken, Marc;
Vanmechelen, Eugeen;
Six, Jan;
Voorde, André;
Martin, Jean-Jacques;
Cras, Patrick

Publication type:

Article

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

Published in:

Clinical Chemistry, 2018, v. 64, n. 6, p. 927, doi. 10.1373/clinchem.2017.283028

By:

Willemse, Eline A. J.;
De Vos, Ann;
Herries, Elizabeth M.;
Andreasson, Ulf;
Engelborghs, Sebastiaan;
van der Flier, Wiesje M.;
Scheltens, Philip;
Crimmins, Dan;
Ladenson, Jack H.;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Fagan, Anne M.;
Blennow, Kaj;
Bjerke, Maria;
Teunissen, Charlotte E.

Publication type:

Article

Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.

Published in:

Acta Neuropathologica, 2021, v. 141, n. 5, p. 709, doi. 10.1007/s00401-021-02275-6

By:

Ashton, Nicholas J.;
Pascoal, Tharick A.;
Karikari, Thomas K.;
Benedet, Andréa L.;
Lantero-Rodriguez, Juan;
Brinkmalm, Gunnar;
Snellman, Anniina;
Schöll, Michael;
Troakes, Claire;
Hye, Abdul;
Gauthier, Serge;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Rosa-Neto, Pedro;
Blennow, Kaj

Publication type:

Article

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.

Published in:

2010

By:

Hertze J;
Minthon L;
Zetterberg H;
Vanmechelen E;
Blennow K;
Hansson O;
Hertze, Joakim;
Minthon, Lennart;
Zetterberg, Henrik;
Vanmechelen, Eugeen;
Blennow, Kaj;
Hansson, Oskar

Publication type:

journal article

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.

Published in:

Journal of Alzheimer's Disease, 2010, v. 21, n. 4, p. 1119, doi. 10.3233/JAD-2010-100207

By:

Hertze, Joakim;
Minthon, Lennart;
Zetterberg, Henrik;
Vanmechelen, Eugeen;
Blennow, Kaj;
Hansson, Oskar

Publication type:

Article

Intra-Individual Stability of CSF Biomarkers for Alzheimer's Disease over Two Years.

Published in:

Journal of Alzheimer's Disease, 2007, v. 12, n. 3, p. 255, doi. 10.3233/JAD-2007-12307

By:

Zetterberg, Henrik;
Pedersen, Mona;
Lind, Karin;
Svensson, Maria;
Rolstad, Sindre;
Eckerström, Carl;
Syversen, Steinar;
Mattsson, Ulla-Britt;
Ysander, Christina;
Mattsson, Niklas;
Nordlund, Arto;
Vanderstichele, Hugo;
Vanmechelen, Eugeen;
Jonsson, Michael;
Edman, Åke;
Blennow, Kaj;
Wallin, Anders

Publication type:

Article

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

Published in:

2007

By:

Zetterberg, Henrik;
Pedersen, Mona;
Lind, Karin;
Svensson, Maria;
Rolstad, Sindre;
Eckerström, Carl;
Syversen, Steinar;
Mattsson, Ulla-Britt;
Ysander, Christina;
Mattsson, Niklas;
Nordlund, Arto;
Vanderstichele, Hugo;
Vanmechelen, Eugeen;
Jonsson, Michael;
Edman, Ake;
Blennow, Kaj;
Wallin, Anders

Publication type:

journal article

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.

Published in:

Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1592, doi. 10.1093/brain/awac333

By:

Janelidze, Shorena;
Bali, Divya;
Ashton, Nicholas J;
Barthélemy, Nicolas R;
Vanbrabant, Jeroen;
Stoops, Erik;
Vanmechelen, Eugeen;
He, Yingxin;
Dolado, Anna Orduña;
Triana-Baltzer, Gallen;
Pontecorvo, Michael J;
Zetterberg, Henrik;
Kolb, Hartmuth;
Vandijck, Manu;
Blennow, Kaj;
Bateman, Randall J;
Hansson, Oskar

Publication type:

Article

No association of CSF biomarkers with APOE{varepsilon}4, plaque and tangle burden in definite Alzheimers disease.

Published in:

Brain: A Journal of Neurology, 2007, v. 130, n. 9, p. 2320

By:

Sebastiaan Engelborghs;
Kristel Sleegers;
Patrick Cras;
Nathalie Brouwers;
Sally Serneels;
Evelyn De Leenheir;
Jean-Jacques Martin;
Eugeen Vanmechelen;
Christine Van Broeckhoven;
Peter Paul De Deyn

Publication type:

Article

Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults.

Published in:

Annals of Neurology, 2022, v. 91, n. 4, p. 548, doi. 10.1002/ana.26308

By:

Meyer, Pierre‐François;
Ashton, Nicholas J.;
Karikari, Thomas K.;
Strikwerda‐Brown, Cherie;
Köbe, Theresa;
Gonneaud, Julie;
Pichet Binette, Alexa;
Ozlen, Hazal;
Yakoub, Yara;
Simrén, Joel;
Pannee, Josef;
Lantero‐Rodriguez, Juan;
Labonté, Anne;
Baker, Suzanne L.;
Schöll, Michael;
Vanmechelen, Eugeen;
Breitner, John C. S.;
Zetterberg, Henrik;
Blennow, Kaj;
Poirier, Judes

Publication type:

Article

Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease.

Published in:

Annals of Clinical & Translational Neurology, 2022, v. 9, n. 5, p. 734, doi. 10.1002/acn3.51553

By:

De Meyer, Steffi;
Vanbrabant, Jeroen;
Schaeverbeke, Jolien M.;
Reinartz, Mariska;
Luckett, Emma S.;
Dupont, Patrick;
Van Laere, Koen;
Stoops, Erik;
Vanmechelen, Eugeen;
Poesen, Koen;
Vandenberghe, Rik

Publication type:

Article

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

Published in:

Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00138

By:

Lehmann, Sylvain;
Delaby, Constance;
Boursier, Guilaine;
Catteau, Cindy;
Ginestet, Nelly;
Tiers, Laurent;
Maceski, Aleksandra;
Navucet, Sophie;
Paquet, Claire;
Dumurgier, Julien;
Vanmechelen, Eugeen;
Vanderstichele, Hugo;
Gabelle, Audrey

Publication type:

Article

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease.

Published in:

Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01762-2

By:

Gaetani, Lorenzo;
Bellomo, Giovanni;
Chiasserini, Davide;
De Rocker, Charlotte;
Goossens, Julie;
Paolini Paoletti, Federico;
Vanmechelen, Eugeen;
Parnetti, Lucilla

Publication type:

Article

Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer's disease.

Published in:

Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01716-8

By:

Bayoumy, Sherif;
Goossens, Julie;
De Rocker, Charlotte;
Sie, Senna Y.;
Barrett, Nolan J.;
van der Flier, Wiesje M.;
Teunissen, Charlotte E.;
Vanmechelen, Eugeen;
Verberk, Inge M. W.

Publication type:

Article

Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkers.

Published in:

Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01685-y

By:

González, Alba Cervantes;
Goossens, Julie;
Campuzano, Elena Vera;
Sala, Isabel;
Sánchez-Saudinós, M. Belén;
Rodríguez-Baz, Íñigo;
Lidón, Laia;
Perlaza, Danna;
Bejanin, Alexandre;
Haapasalo, Annakaisa;
Fortea, Juan;
Alcolea, Daniel;
Lleó, Alberto;
Vanmechelen, Eugeen;
Belbin, Olivia

Publication type:

Article

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.

Published in:

Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01620-7

By:

Kovacech, Branislav;
Cullen, Nicholas C.;
Novak, Petr;
Hanes, Jozef;
Kontsekova, Eva;
Katina, Stanislav;
Parrak, Vojtech;
Fresser, Michal;
Vanbrabant, Jeroen;
Feldman, Howard H.;
Winblad, Bengt;
Stoops, Erik;
Vanmechelen, Eugeen;
Zilka, Norbert

Publication type:

Article